EIF4A3
Eukaryotic initiation factor 4A-III
Also known as: DDX48, EIF4AIII, Fal1, IF4A3_HUMAN, KIAA0111
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P38919
- Gene
- EIF4A3
- Ensembl
- ENSG00000141543
- Chromosome
- 17
- Canonical length
- 411 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the DEAD box protein family. DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure, such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. The protein encoded by this gene is a nuclear matrix protein. Its amino acid sequence is highly similar to the amino acid sequences of the translation initiation factors eIF4AI and eIF4AII, two other members of the DEAD box protein family. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
411 residues, UniProt reviewed canonical sequence.
>P38919|EIF4A3
1 MATTATMATS GSARKRLLKE EDMTKVEFET SEEVDVTPTF DTMGLREDLL RGIYAYGFEK
61 PSAIQQRAIK QIIKGRDVIA QSQSGTGKTA TFSISVLQCL DIQVRETQAL ILAPTRELAV
121 QIQKGLLALG DYMNVQCHAC IGGTNVGEDI RKLDYGQHVV AGTPGRVFDM IRRRSLRTRA
181 IKMLVLDEAD EMLNKGFKEQ IYDVYRYLPP ATQVVLISAT LPHEILEMTN KFMTDPIRIL
241 VKRDELTLEG IKQFFVAVER EEWKFDTLCD LYDTLTITQA VIFCNTKRKV DWLTEKMREA
301 NFTVSSMHGD MPQKERESIM KEFRSGASRV LISTDVWARG LDVPQVSLII NYDLPNNREL
361 YIHRIGRSGR YGRKGVAINF VKNDDIRILR DIEQYYSTQI DEMPMNVADL ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against EIF4A3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 176 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 176 nTPM
- esophagus: 86 nTPM
- urinary bladder: 78 nTPM
- adrenal gland: 77 nTPM
- thymus: 73 nTPM
- tonsil: 70 nTPM
Single-cell type
- pdcs: 421 nCPM
- urothelial cells: 406 nCPM
- esophageal apical cells: 350 nCPM
- syncytiotrophoblasts: 342 nCPM
- endometrial luminal cells: 340 nCPM
- extravillous trophoblasts: 307 nCPM
Immune cell
- plasmacytoid DC: 326 nTPM
- total PBMC: 232 nTPM
- myeloid DC: 200 nTPM
- intermediate monocyte: 175 nTPM
- classical monocyte: 167 nTPM
- T-reg: 159 nTPM
Brain region
- cerebral cortex: 37 nTPM
- white matter: 32 nTPM
- choroid plexus: 28 nTPM
- spinal cord: 28 nTPM
- hippocampal formation: 27 nTPM
- cerebellum: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EIF4A3.
Disease | AllUniProt
Conditions EIF4A3 is implicated in, by any mechanism.
- Richieri-Costa-Pereira syndrome (RCPS) MIM:268305
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 55 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Richieri Costa-Pereira syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.12
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.02
- DepMap mean gene effect
- -2.29
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- associative learning
- cellular response to brain-derived neurotrophic factor stimulus
- embryonic cranial skeleton morphogenesis
- exploration behavior
- mRNA export from nucleus
- mRNA splicing, via spliceosome
- negative regulation of excitatory postsynaptic potential
- negative regulation of translation
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
- positive regulation of translation
- regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
- regulation of translation at postsynapse, modulating synaptic transmission
- rRNA processing
- cellular response to selenite ion
- negative regulation of selenocysteine incorporation
Molecular functions
- ATP binding
- ATP hydrolysis activity
- mRNA binding
- poly(A) binding
- ribonucleoprotein complex binding
- RNA binding
- RNA helicase activity
- RNA stem-loop binding
- selenocysteine insertion sequence binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATP-dependent RNA helicase DEAD-box, conserved site
- Helicase, C-terminal domain-like
- DEAD/DEAH-box helicase domain
- Helicase superfamily 1/2, ATP-binding domain
- RNA helicase, DEAD-box type, Q motif
- P-loop containing nucleoside triphosphate hydrolase
- DEAD/DEAH box helicase
- Helicase conserved C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EIF4A3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EIF4A3 as an antibody target. Whether an autoantibody or antibody against EIF4A3 could matter depends on whether native EIF4A3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EIF4A3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EIF4A3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...